menu
    • menu

    Company profile for Celcuity

    NEW Drugs in Dev: 1
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Celcuity was founded in 2012 by Brian Sullivan and Lance Laing, PhD, to develop a better way to diagnose and treat the cellular abnormalities that drive tumor growth. Our team of drug development scientists, biochemists, molecular biologists, and diagnostics experts are advancing new targeted therapies for cancer using an integrated therapeutic and companion diagnostic strategy that leverages our CELsignia platform. This allow...
    Celcuity was founded in 2012 by Brian Sullivan and Lance Laing, PhD, to develop a better way to diagnose and treat the cellular abnormalities that drive tumor growth. Our team of drug development scientists, biochemists, molecular biologists, and diagnostics experts are advancing new targeted therapies for cancer using an integrated therapeutic and companion diagnostic strategy that leverages our CELsignia platform. This allows Celcuity to discover new cancer sub-types molecular diagnostics cannot detect.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CelcuityUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    16305 – 36th Avenue North Suite 100 Minneapolis, MN 55446
    Telephone
    Telephone
    763-473-0341
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.celcuity.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/celcuity/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Celcuity Announces Public Offering of Convertible Senior Notes
    Celcuity Announces Public Offering of Convertible Senior Notes

    03 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/03/3305935/0/en/celcuity-inc-announces-public-offering-of-convertible-senior-notes-due-2032.html

    GLOBENEWSWIRE
    03 Jun 2026
    Share Share
    Celcuity Slides Despite 'Practice-Changing' Breast Cancer Data
    Celcuity Slides Despite 'Practice-Changing' Breast Cancer Data

    03 Jun 2026

    // PRESS RELEASE

    https://ir.celcuity.com/news-releases/news-release-details/celcuitys-gedatolisib-combination-regimens-doubled-likelihood

    PRESS RELEASE
    03 Jun 2026
    Share Share
    Gedatolisib Doubles PFS vs Alpelisib in Ph3 Breast Cancer Trial
    Gedatolisib Doubles PFS vs Alpelisib in Ph3 Breast Cancer Trial

    02 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/02/3305149/0/en/celcuity-s-gedatolisib-combination-regimens-doubled-the-likelihood-of-survival-without-disease-progression-or-death-compared-to-alpelisib-plus-fulvestrant-in-the-pik3ca-mutant-coho.html

    GLOBENEWSWIRE
    02 Jun 2026
    Share Share
    Celcuity to Discuss VIKTORIA-1 PIK3CA Cohort Results
    Celcuity to Discuss VIKTORIA-1 PIK3CA Cohort Results

    01 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/01/3304375/0/en/celcuity-to-hold-conference-call-to-discuss-results-for-the-pik3ca-mutant-cohort-of-the-phase-3-viktoria-1-clinical-trial-of-gedatolisib-regimens-in-hr-her-advanced-breast-cancer-o.html

    GLOBENEWSWIRE
    01 Jun 2026
    Share Share
    Celcuity to Present at Upcoming Investor Conferences
    Celcuity to Present at Upcoming Investor Conferences

    28 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/28/3302849/0/en/celcuity-to-participate-in-upcoming-investor-conferences.html

    GLOBENEWSWIRE
    28 May 2026
    Share Share
    Celcuity's VIKTORIA-2 Expands to Endocrine-Sensitive Patients
    Celcuity's VIKTORIA-2 Expands to Endocrine-Sensitive Patients

    14 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/14/3294803/0/en/celcuity-s-phase-3-viktoria-2-trial-of-gedatolisib-as-a-first-line-treatment-for-hr-her2-advanced-breast-cancer-expanding-to-include-endocrine-sensitive-patients.html

    GLOBENEWSWIRE
    14 May 2026
    Share Share

    ABOUT THIS PAGE

    Contact Celcuity and get a quotation

    Celcuity is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find Gedatolisib bulk offered by Celcuity

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search